414 related articles for article (PubMed ID: 19166904)
1. Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases.
Cahill CM; Lahiri DK; Huang X; Rogers JT
Biochim Biophys Acta; 2009 Jul; 1790(7):615-28. PubMed ID: 19166904
[TBL] [Abstract][Full Text] [Related]
2. Novel 5' untranslated region directed blockers of iron-regulatory protein-1 dependent amyloid precursor protein translation: implications for down syndrome and Alzheimer's disease.
Bandyopadhyay S; Cahill C; Balleidier A; Huang C; Lahiri DK; Huang X; Rogers JT
PLoS One; 2013; 8(7):e65978. PubMed ID: 23935819
[TBL] [Abstract][Full Text] [Related]
3. Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease.
Rogers JT; Bush AI; Cho HH; Smith DH; Thomson AM; Friedlich AL; Lahiri DK; Leedman PJ; Huang X; Cahill CM
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1282-7. PubMed ID: 19021541
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Iron-Response Elements of the mRNAs for the Alzheimer's Amyloid Precursor Protein and Ferritin to Treat Acute Lead and Manganese Neurotoxicity.
Rogers JT; Xia N; Wong A; Bakshi R; Cahill CM
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823541
[TBL] [Abstract][Full Text] [Related]
5. An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript.
Rogers JT; Randall JD; Cahill CM; Eder PS; Huang X; Gunshin H; Leiter L; McPhee J; Sarang SS; Utsuki T; Greig NH; Lahiri DK; Tanzi RE; Bush AI; Giordano T; Gullans SR
J Biol Chem; 2002 Nov; 277(47):45518-28. PubMed ID: 12198135
[TBL] [Abstract][Full Text] [Related]
6. Iron-responsive-like elements and neurodegenerative ferroptosis.
Rogers JT; Cahill CM
Learn Mem; 2020 Sep; 27(9):395-413. PubMed ID: 32817306
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: maintenance of brain iron homeostasis.
Bandyopadhyay S; Rogers JT
Biochem Pharmacol; 2014 Apr; 88(4):486-94. PubMed ID: 24513321
[TBL] [Abstract][Full Text] [Related]
8. Metal and inflammatory targets for Alzheimer's disease.
Rogers JT; Lahiri DK
Curr Drug Targets; 2004 Aug; 5(6):535-51. PubMed ID: 15270200
[TBL] [Abstract][Full Text] [Related]
9. Iron regulatory protein (IRP)-iron responsive element (IRE) signaling pathway in human neurodegenerative diseases.
Zhou ZD; Tan EK
Mol Neurodegener; 2017 Oct; 12(1):75. PubMed ID: 29061112
[TBL] [Abstract][Full Text] [Related]
10. Physiological and pathological aspects of Abeta in iron homeostasis via 5'UTR in the APP mRNA and the therapeutic use of iron-chelators.
Avramovich-Tirosh Y; Amit T; Bar-Am O; Weinreb O; Youdim MB
BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S2. PubMed ID: 19090990
[TBL] [Abstract][Full Text] [Related]
11. A role for amyloid precursor protein translation to restore iron homeostasis and ameliorate lead (Pb) neurotoxicity.
Rogers JT; Venkataramani V; Washburn C; Liu Y; Tummala V; Jiang H; Smith A; Cahill CM
J Neurochem; 2016 Aug; 138(3):479-94. PubMed ID: 27206843
[TBL] [Abstract][Full Text] [Related]
12. The integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5'-untranslated region.
Venti A; Giordano T; Eder P; Bush AI; Lahiri DK; Greig NH; Rogers JT
Ann N Y Acad Sci; 2004 Dec; 1035():34-48. PubMed ID: 15681799
[TBL] [Abstract][Full Text] [Related]
13. Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1.
Cho HH; Cahill CM; Vanderburg CR; Scherzer CR; Wang B; Huang X; Rogers JT
J Biol Chem; 2010 Oct; 285(41):31217-32. PubMed ID: 20558735
[TBL] [Abstract][Full Text] [Related]
14. FDA-preapproved drugs targeted to the translational regulation and processing of the amyloid precursor protein.
Morse LJ; Payton SM; Cuny GD; Rogers JT
J Mol Neurosci; 2004; 24(1):129-36. PubMed ID: 15314261
[TBL] [Abstract][Full Text] [Related]
15. Novel upregulation of amyloid-β precursor protein (APP) by microRNA-346 via targeting of APP mRNA 5'-untranslated region: Implications in Alzheimer's disease.
Long JM; Maloney B; Rogers JT; Lahiri DK
Mol Psychiatry; 2019 Mar; 24(3):345-363. PubMed ID: 30470799
[TBL] [Abstract][Full Text] [Related]
16. Metal specificity of an iron-responsive element in Alzheimer's APP mRNA 5'untranslated region, tolerance of SH-SY5Y and H4 neural cells to desferrioxamine, clioquinol, VK-28, and a piperazine chelator.
Bandyopadhyay S; Huang X; Cho H; Greig NH; Youdim MB; Rogers JT
J Neural Transm Suppl; 2006; (71):237-47. PubMed ID: 17447434
[TBL] [Abstract][Full Text] [Related]
17. NEURODEGENERATION. Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein.
Goedert M
Science; 2015 Aug; 349(6248):1255555. PubMed ID: 26250687
[TBL] [Abstract][Full Text] [Related]
18. Metal Ions in Alzheimer's Disease: A Key Role or Not?
Liu Y; Nguyen M; Robert A; Meunier B
Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
[TBL] [Abstract][Full Text] [Related]
19. Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease.
Suh YH; Checler F
Pharmacol Rev; 2002 Sep; 54(3):469-525. PubMed ID: 12223532
[TBL] [Abstract][Full Text] [Related]
20. The alpha-synuclein 5'untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen.
Rogers JT; Mikkilineni S; Cantuti-Castelvetri I; Smith DH; Huang X; Bandyopadhyay S; Cahill CM; Maccecchini ML; Lahiri DK; Greig NH
J Neural Transm (Vienna); 2011 Mar; 118(3):493-507. PubMed ID: 21221670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
